Back to Journals » Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine


ISSN: 1178-7066

Editor-in-Chief: Dr Martin H Bluth

An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Latest articles:

- 5 records -

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy

He J, Wang Z, Wang Y, Zou T, Li XP, Cao L, Chen J

Pharmacogenomics and Personalized Medicine 2021, 14:1193-1203

Published Date: 18 September 2021

The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction

Zhang L, Zheng Z, Ma W, Zhang S, Xue F, Wang H, He Y, Ye F, Zhou S, Wen Y, Li X, Huang W, Huang M, Li J, Wang Z

Pharmacogenomics and Personalized Medicine 2021, 14:1185-1192

Published Date: 17 September 2021

 

Read more articles